Amphastar Pharmaceuticals, Inc. (AMPH)
25.14
-0.90
(-3.46%)
USD |
NASDAQ |
Oct 23, 16:00
25.00
-0.14
(-0.56%)
After-Hours: 20:00
Amphastar Pharmaceuticals Price to Book Value : 1.392 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 1.392 |
| October 22, 2026 | 1.442 |
| October 21, 2026 | 1.451 |
| October 20, 2026 | 1.436 |
| October 19, 2026 | 1.447 |
| October 16, 2026 | 1.432 |
| October 15, 2026 | 1.463 |
| October 14, 2026 | 1.444 |
| October 13, 2026 | 1.442 |
| October 12, 2026 | 1.482 |
| October 09, 2026 | 1.474 |
| October 08, 2026 | 1.429 |
| October 07, 2026 | 1.414 |
| October 06, 2026 | 1.435 |
| October 05, 2026 | 1.405 |
| October 02, 2026 | 1.408 |
| October 01, 2026 | 1.404 |
| September 30, 2026 | 1.429 |
| September 29, 2026 | 1.477 |
| September 28, 2026 | 1.517 |
| September 25, 2026 | 1.447 |
| September 24, 2026 | 1.454 |
| September 23, 2026 | 1.382 |
| September 22, 2026 | 1.347 |
| September 21, 2026 | 1.355 |
| Date | Value |
|---|---|
| September 18, 2026 | 1.308 |
| September 17, 2026 | 1.319 |
| September 16, 2026 | 1.326 |
| September 15, 2026 | 1.309 |
| September 14, 2026 | 1.324 |
| September 11, 2026 | 1.317 |
| September 10, 2026 | 1.303 |
| September 09, 2026 | 1.276 |
| September 08, 2026 | 1.270 |
| September 04, 2026 | 1.284 |
| September 03, 2026 | 1.32 |
| September 02, 2026 | 1.314 |
| September 01, 2026 | 1.271 |
| August 31, 2026 | 1.248 |
| August 28, 2026 | 1.219 |
| August 27, 2026 | 1.212 |
| August 26, 2026 | 1.219 |
| August 25, 2026 | 1.217 |
| August 24, 2026 | 1.192 |
| August 21, 2026 | 1.196 |
| August 20, 2026 | 1.200 |
| August 19, 2026 | 1.204 |
| August 18, 2026 | 1.182 |
| August 17, 2026 | 1.155 |
| August 14, 2026 | 1.158 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Viatris, Inc. | 1.458 |
| Johnson & Johnson | 7.789 |
| Eli Lilly & Co. | 35.39 |
| Merck & Co., Inc. | 8.552 |
| Pfizer Inc. | 2.009 |
Price to Book Value Related Metrics
| PE Ratio | 14.73 |
| PS Ratio | 1.597 |
| Price to Free Cash Flow | 7.626 |
| Price | 25.14 |
| Earnings Yield | 6.79% |
| Market Cap | 1.069B |
| Operating PE Ratio | 10.20 |
| Normalized PE Ratio | 16.64 |